long consolidation and parallel channel breakout with volume
ZYDUSLIFE
Time frame- DAILY
*Resistance - 200DMA or 380 once closing above 380 than upside till 436 is possible.
*Support - 100 DMA
*Short term to medium term
*Reason- long consolidation, and parallel channel breakout with volume, taken support on 100DMA
Disclaimer:- I am not SEBI registered analyst. Only for information and education purpose. Please consult your adviser before investing.
#technicalanalysis #technicalanalyst #swingtrading #swingtrader #fundamentalanalysis #bullish #chartoftheweek #trading #tradingstrategy #stockmarket #stockmarketindia #stocks #stockmarketnews #stockstowatch #stockstobuy #stockoptions #longterminvestment #investment #investmentopportunities
#derivatives #derivativestrading #index #indexinvesting #optiontrading #chartanalysis #trader #tradingsignals #tradingview #education #breakout #pattern #information #investing #consolidation #consult #supporting #volume #long #ZYDUSLIFE #PHARMA
Time frame- DAILY
*Resistance - 200DMA or 380 once closing above 380 than upside till 436 is possible.
*Support - 100 DMA
*Short term to medium term
*Reason- long consolidation, and parallel channel breakout with volume, taken support on 100DMA
Disclaimer:- I am not SEBI registered analyst. Only for information and education purpose. Please consult your adviser before investing.
#technicalanalysis #technicalanalyst #swingtrading #swingtrader #fundamentalanalysis #bullish #chartoftheweek #trading #tradingstrategy #stockmarket #stockmarketindia #stocks #stockmarketnews #stockstowatch #stockstobuy #stockoptions #longterminvestment #investment #investmentopportunities
#derivatives #derivativestrading #index #indexinvesting #optiontrading #chartanalysis #trader #tradingsignals #tradingview #education #breakout #pattern #information #investing #consolidation #consult #supporting #volume #long #ZYDUSLIFE #PHARMA
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。